Literature DB >> 6176155

Nephelometric determination of serum amylase and lipase in naturally occurring azotemia in the dog.

A E Wagner, D W Macy.   

Abstract

Serum amylase and lipase were measured in 32 healthy dogs and in 55 dogs with serum urea nitrogen values greater than 40 mg/dl, using a nephelometric analyzer (Coleman analyzer model 91). Mean serum amylase and lipase values in normal dogs were 1,085.48 units and 3.98 units, respectively. In dogs with azotemia, the mean serum amylase and lipase values were 1,822.79 units and 12.57 units, respectively. Serum urea nitrogen values could not be correlated with amylase or lipase values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176155

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.

Authors:  R M Jacobs; C L Swenson; D J Davenport; R J Murtaugh
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

2.  Evaluation of 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester lipase concentrations in cats with kidney disease and with normal SNAP fPL.

Authors:  Anne-Sophie Bua; Carolyn Grimes; Guy Beauchamp; Marilyn E Dunn
Journal:  Can Vet J       Date:  2020-07       Impact factor: 1.008

3.  Hyperlipasemia in critically ill dogs with and without acute pancreatitis: Prevalence, underlying diseases, predictors, and outcome.

Authors:  Julia K Prümmer; Judith Howard; Lisa M Grandt; Rafael Obrador de Aguilar; Felix Meneses; Laureen M Peters
Journal:  J Vet Intern Med       Date:  2020-09-18       Impact factor: 3.333

4.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.